Source: Overseas Network
Image source/ Fuji TV
Overseas network november 25, Japan's Toshiba company announced on the 25th that the company has developed a new technology, with 99% accuracy from 1 drop of blood to detect 13 kinds of cancer, will start empirical trials in 2020. Tokyo Medical University and the National Cancer Research Center are also participating in the research and aim to put it into full use within a few years.
According to Japan's Kyodo News Agency, this technology can detect 13 kinds of cancers such as breast cancer, pancreatic cancer, esophageal cancer, stomach cancer, and colorectal cancer at an early stage by examining the type and concentration of molecules called "microrna" (microrna) secreted in the blood. After practical use, it is expected to improve the survival rate of patients.
Toshiba Corporation has also successfully developed chips and small instruments that can easily detect RNA in a short period of time. It is said that the relevant equipment can detect the results within 2 hours, and the price is controlled within 20,000 yen (about 1294 yuan). However, simple tests alone cannot determine what kind of cancer you have.
Toshiba Corporation has developed related examination techniques based on the results of microrna medicine research by Tokyo Medical University and the National Cancer Research Center. According to previous reports, researchers at institutions such as the Toray Group are also developing such technologies. But Toshiba said its technology "has advantages in terms of accuracy, time and cost." The details of the study will be presented at the 42nd Annual Meeting of the Japanese Society for Molecular Biology in Fukuoka, Japan, from December 3 to 8. (Overseas Network Wang Shanning)
This article is a copyrighted work and unauthorized reproduction is strictly prohibited. Overseas vision, China's position, browse the official website of the overseas edition of the People's Daily - overseas network or "Haike" client, one step ahead to obtain authoritative information.